Liby, Karen T.
Indiana University School of Medicine
5 papers on CoChatORCID 0000-0003-3317-3437
Most cited papers
- Verified
NRF2 and cancer: the good, the bad and the importance of context
Sporn, M. B., & Liby, K. T. (2012) · Nature Reviews Cancer
Genomics, phytochemicals, and oxidative stressBioactive Compounds and Antitumor Agents
Cited by 1,067
- Verified
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
Liby, K. T., Yore, M. M., & Sporn, M. B. (2007) · Nature Reviews Cancer
Natural product bioactivities and synthesisPhytochemical Studies and Bioactivities
Cited by 637
- Verified
Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice
Sussan, T. E., Rangasamy, T., Blake, D. J., Malhotra, D., El-Haddad, H., Bedja, D., Yates, M. S., Kombairaju, P., Yamamoto, M., Liby, K. T., et al. (2009) · Proceedings of the National Academy of Sciences
Chronic Obstructive Pulmonary Disease (COPD) ResearchGenomics, phytochemicals, and oxidative stress
Cited by 346
- Verified
The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling
Liby, K., Hock, T., Yore, M. M., Suh, N., Place, A. E., Risingsong, R., Williams, C. R., Royce, D. B., Honda, T., Honda, Y., et al. (2005) · Cancer Research
Heme Oxygenase-1 and Carbon MonoxideGenomics, phytochemicals, and oxidative stress
Cited by 283
- Verified
Health position paper and redox perspectives – Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases
Cuadrado, A., Cazalla, E., Bach, A., Bathish, B., Naidu, S. D., DeNicola, G. M., Dinkova-Kostova, A. T., Fernández-Ginés, R., Grochot-Przeczek, A., Hayes, J. D., et al. (2025) · Redox Biology
Genomics, phytochemicals, and oxidative stressRedox biology and oxidative stress
Cited by 28
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free